Literature DB >> 16751344

Suz12 binds to silenced regions of the genome in a cell-type-specific manner.

Sharon L Squazzo1, Henriette O'Geen, Vitalina M Komashko, Sheryl R Krig, Victor X Jin, Sung-wook Jang, Raphael Margueron, Danny Reinberg, Roland Green, Peggy J Farnham.   

Abstract

Suz12 is a component of the Polycomb group complexes 2, 3, and 4 (PRC 2/3/4). These complexes are critical for proper embryonic development, but very few target genes have been identified in either mouse or human cells. Using a variety of ChIP-chip approaches, we have identified a large set of Suz12 target genes in five different human and mouse cell lines. Interestingly, we found that Suz12 target promoters are cell type specific, with transcription factors and homeobox proteins predominating in embryonal cells and glycoproteins and immunoglobulin-related proteins predominating in adult tumors. We have also characterized the localization of other components of the PRC complex with Suz12 and investigated the overall relationship between Suz12 binding and markers of active versus inactive chromatin, using both promoter arrays and custom tiling arrays. Surprisingly, we find that the PRC complexes can be localized to discrete binding sites or spread through large regions of the mouse and human genomes. Finally, we have shown that some Suz12 target genes are bound by OCT4 in embryonal cells and suggest that OCT4 maintains stem cell self-renewal, in part, by recruiting PRC complexes to certain genes that promote differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751344      PMCID: PMC1484456          DOI: 10.1101/gr.5306606

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  32 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

Review 2.  The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

Authors:  Ru Cao; Yi Zhang
Journal:  Curr Opin Genet Dev       Date:  2004-04       Impact factor: 5.578

3.  Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

Authors:  Andrei Kuzmichev; Kenichi Nishioka; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

4.  Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.

Authors:  H Yuan; N Corbi; C Basilico; L Dailey
Journal:  Genes Dev       Date:  1995-11-01       Impact factor: 11.361

5.  Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.

Authors:  Diego Pasini; Adrian P Bracken; Michael R Jensen; Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

Review 6.  Stem cells and cancer; the polycomb connection.

Authors:  Merel E Valk-Lingbeek; Sophia W M Bruggeman; Maarten van Lohuizen
Journal:  Cell       Date:  2004-08-20       Impact factor: 41.582

7.  Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.

Authors:  Antonis Kirmizis; Stephanie M Bartley; Andrei Kuzmichev; Raphael Margueron; Danny Reinberg; Roland Green; Peggy J Farnham
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

8.  SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex.

Authors:  Ru Cao; Yi Zhang
Journal:  Mol Cell       Date:  2004-07-02       Impact factor: 17.970

9.  New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.

Authors:  V Botquin; H Hess; G Fuhrmann; C Anastassiadis; M K Gross; G Vriend; H R Schöler
Journal:  Genes Dev       Date:  1998-07-01       Impact factor: 11.361

10.  The eed mutation disrupts anterior mesoderm production in mice.

Authors:  C Faust; A Schumacher; B Holdener; T Magnuson
Journal:  Development       Date:  1995-02       Impact factor: 6.868

View more
  157 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  Integrative epigenomic and genomic analysis of malignant pheochromocytoma.

Authors:  Johanna Sandgren; Robin Andersson; Alvaro Rada-Iglesias; Stefan Enroth; Goran Akerstrom; Jan P Dumanski; Jan Komorowski; Gunnar Westin; Claes Wadelius
Journal:  Exp Mol Med       Date:  2010-07-31       Impact factor: 8.718

3.  Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.

Authors:  Leo L Studach; Stephan Menne; Stefano Cairo; Marie Annick Buendia; Ronald L Hullinger; Lydie Lefrançois; Philippe Merle; Ourania M Andrisani
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

Review 4.  Helper T-cell differentiation and plasticity: insights from epigenetics.

Authors:  Kiyoshi Hirahara; Golnaz Vahedi; Kamran Ghoreschi; Xiang-Ping Yang; Shingo Nakayamada; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

5.  Comparison of sample preparation methods for ChIP-chip assays.

Authors:  Henriette O'Geen; Charles M Nicolet; Kim Blahnik; Roland Green; Peggy J Farnham
Journal:  Biotechniques       Date:  2006-11       Impact factor: 1.993

6.  Profile of histone lysine methylation across transcribed mammalian chromatin.

Authors:  Christopher R Vakoc; Mira M Sachdeva; Hongxin Wang; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

7.  Hyperconserved CpG domains underlie Polycomb-binding sites.

Authors:  Amos Tanay; Anne H O'Donnell; Marc Damelin; Timothy H Bestor
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

8.  Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.

Authors:  Julien Vandamme; Pamela Völkel; Claire Rosnoblet; Perrine Le Faou; Pierre-Olivier Angrand
Journal:  Mol Cell Proteomics       Date:  2011-01-31       Impact factor: 5.911

9.  Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.

Authors:  Katharina Steinmann; David N Cooper; Lan Kluwe; Nadia A Chuzhanova; Cornelia Senger; Eduard Serra; Conxi Lazaro; Montserrat Gilaberte; Katharina Wimmer; Viktor-Felix Mautner; Hildegard Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

10.  An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.

Authors:  Christos Polytarchou; Dimitrios Iliopoulos; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.